<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: This study investigated the relationship of <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> and survival in a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cohort </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Clinical and pathological data, along with anthropometric and follow-up data, were collected from 344 consecutive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Serum samples at diagnosis were analysed by immunoassay for adiponectin, C-reactive protein (CRP), vascular endothelial growth factor-A (VEGF-A), angiopoietin-2 (Ang-2), insulin-like growth factor-1 (IGF-1), insulin and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Serum Ang-2 and VEGF-A levels increased with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> T stage (P=0.007 and P=0.025, respectively) and N stage (P=0.02 and P=0.03, respectively), and correlated with CRP levels (r=0.43, P&lt;0.001 and r=0.23, P&lt;0.001, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Angiopoietin-2 correlated with C-<z:chebi fb="7" ids="16670">peptide</z:chebi> (r=0.14, P=0.007) and VEGF-A with IGF-1 in males (r=0.25, P=0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Kaplan-Meier analysis showed that patients with high serum levels of CRP and Ang-2 had significantly reduced survival (both Pâ‰¤0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>After adjusting for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage and age, Ang-2 remained a significant predictor of survival </plain></SENT>
<SENT sid="7" pm="."><plain>The CRP levels were inversely associated with survival in American Joint Committee on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stage II patients (P=0.038), suggesting that CRP could be used to support treatment decisions in this subgroup </plain></SENT>
<SENT sid="8" pm="."><plain>Serum markers and anthropometric measures of <z:hpo ids='HP_0001513'>obesity</z:hpo> correlated with each other, but not with survival </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our study supports the concept that <z:hpo ids='HP_0001513'>obesity</z:hpo>-related <z:mp ids='MP_0001845'>inflammation</z:mp>, rather than <z:hpo ids='HP_0001513'>obesity</z:hpo> itself, is associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression and survival </plain></SENT>
<SENT sid="10" pm="."><plain>The study confirms serum Ang-2 as a predictive marker for outcome of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>